Literature DB >> 7544555

Development of monoclonal antibodies and capture immunoassays for feline immunodeficiency virus.

M J Dreitz1, S W Dow, S A Fiscus, E A Hoover.   

Abstract

We generated monoclonal antibodies (MAB) against feline immunodeficiency virus (FIV) and characterized these MAB by single competition enzyme immunoassays (EIA), immunoblot analysis, and radioimmunoprecipitation. Four MAB identified 3 distinct epitopes of the FIV p24/26 gag major core protein. One MAB recognized the p16/17 gag protein; none recognized envelope proteins. We developed an FIV p26 antigen capture EIA that proved more sensitive (0.5 ng of p26/ml), less expensive, and less time-consuming than reverse transcriptase assay. The same MAB were used to develop an antibody EIA specific for FIV p26. The MAB and capture assays reported should prove useful in FIV diagnosis and research.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544555

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  10 in total

1.  Accessory genes confer a high replication rate to virulent feline immunodeficiency virus.

Authors:  Ryan M Troyer; Jesse Thompson; John H Elder; Sue VandeWoude
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

2.  Frequent perinatal transmission of feline immunodeficiency virus by chronically infected cats.

Authors:  L L O'Neil; M J Burkhard; E A Hoover
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

3.  In vivo monocyte tropism of pathogenic feline immunodeficiency viruses.

Authors:  S W Dow; C K Mathiason; E A Hoover
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

4.  Early pathogenesis of transmucosal feline immunodeficiency virus infection.

Authors:  Leslie A Obert; Edward A Hoover
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

5.  Immunohistochemical localization of feline immunodeficiency virus using native species antibodies.

Authors:  Arlin B Rogers; Candace K Mathiason; Edward A Hoover
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

6.  Induction of accelerated feline immunodeficiency virus disease by acute-phase virus passage.

Authors:  L J Diehl; C K Mathiason-Dubard; L L O'Neil; L A Obert; E A Hoover
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

7.  Gamma interferon/interleukin 10 balance in tissue lymphocytes correlates with down modulation of mucosal feline immunodeficiency virus infection.

Authors:  Paul R Avery; Edward A Hoover
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

8.  Three pathogens in sympatric populations of pumas, bobcats, and domestic cats: implications for infectious disease transmission.

Authors:  Sarah N Bevins; Scott Carver; Erin E Boydston; Lisa M Lyren; Mat Alldredge; Kenneth A Logan; Seth P D Riley; Robert N Fisher; T Winston Vickers; Walter Boyce; Mo Salman; Michael R Lappin; Kevin R Crooks; Sue VandeWoude
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

9.  FIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challenge.

Authors:  Craig Miller; Mauren Emanuelli; Elizabeth Fink; Esther Musselman; Ryan Mackie; Ryan Troyer; John Elder; Sue VandeWoude
Journal:  NPJ Vaccines       Date:  2018-04-30       Impact factor: 7.344

10.  Pathogenesis of oral FIV infection.

Authors:  Craig Miller; Karen Boegler; Scott Carver; Martha MacMillan; Helle Bielefeldt-Ohmann; Sue VandeWoude
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.